ID   PDE9A_PANTR             Reviewed;         593 AA.
AC   H2QL32; K7AGW3;
DT   27-MAY-2015, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 1.
DT   22-JUL-2015, entry version 25.
DE   RecName: Full=High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A {ECO:0000305};
DE            EC=3.1.4.35 {ECO:0000250|UniProtKB:O76083};
GN   Name=PDE9A;
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16136131; DOI=10.1038/nature04072;
RG   Chimpanzee sequencing and analysis consortium;
RT   "Initial sequence of the chimpanzee genome and comparison with the
RT   human genome.";
RL   Nature 437:69-87(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Maudhoo M.D., Meehan D.T., Norgren R.B. Jr.;
RT   "De novo assembly of the reference chimpanzee transcriptome from
RT   NextGen mRNA sequences.";
RL   Submitted (OCT-2012) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000244|PDB:4QGE}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH ZINC; MAGNESIUM
RP   AND INHIBITOR 3R, AND ENZYME REGULATION.
RX   PubMed=25432025; DOI=10.1021/jm500836h;
RA   Shao Y.X., Huang M., Cui W., Feng L.J., Wu Y., Cai Y., Li Z., Zhu X.,
RA   Liu P., Wan Y., Ke H., Luo H.B.;
RT   "Discovery of a phosphodiesterase 9A inhibitor as a potential
RT   hypoglycemic agent.";
RL   J. Med. Chem. 57:10304-10313(2014).
CC   -!- FUNCTION: Specifically hydrolyzes the second messenger cGMP, which
CC       is a key regulator of many important physiological processes.
CC       Highly specific: compared to other members of the cyclic
CC       nucleotide phosphodiesterase family, has the highest affinity and
CC       selectivity for cGMP. Specifically regulates natriuretic-peptide-
CC       dependent cGMP signaling in heart, acting as a regulator of
CC       cardiac hypertrophy in myocytes and muscle. Does not regulate
CC       nitric oxide-dependent cGMP in heart. Additional experiments are
CC       required to confirm whether its ability to hydrolyze natriuretic-
CC       peptide-dependent cGMP is specific to heart or is a general
CC       feature of the protein. In brain, involved in cognitive function,
CC       such as learning and long-term memory.
CC       {ECO:0000250|UniProtKB:O76083, ECO:0000250|UniProtKB:Q8QZV1}.
CC   -!- CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =
CC       guanosine 5'-phosphate. {ECO:0000250|UniProtKB:O76083}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC       Note=Binds 1 Zn(2+) ion per subunit. Binds 2 divalent metal
CC       cations per subunit: site 1 preferentially binds zinc, while site
CC       2 has a preference for magnesium. Tightly binds zinc.
CC       {ECO:0000250|UniProtKB:O76083};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O76083};
CC       Note=Binds 1 Mg(2+) ions per subunit. Binds 2 divalent metal
CC       cations per subunit: site 1 preferentially binds zinc, while site
CC       2 has a preference for magnesium. Binds magnesium less tightly
CC       than zinc. {ECO:0000250|UniProtKB:O76083};
CC   -!- ENZYME REGULATION: Specifically inhibited by 3r ((R)-2-((1-
CC       Cyclopentyl-4-hydroxy-1H-pyrazolo[3,4-d]pyrimidin-6- yl)amino)-N-
CC       (4-methoxyphenyl)propanamide): inhibitor forms a hydrogen bond
CC       with Tyr-484 and Gln-513. {ECO:0000269|PubMed:25432025}.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from
CC       3',5'-cyclic GMP: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:O76083}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:O76083}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:O76083}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:O76083}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:O76083}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:O76083}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=H2QL32-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=H2QL32-2; Sequence=VSP_057676;
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE9 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BS000229; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BS000230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; GABC01010554; JAA00784.1; -; mRNA.
DR   RefSeq; XP_001140087.1; XM_001140087.4. [H2QL32-2]
DR   RefSeq; XP_001140174.1; XM_001140174.4. [H2QL32-1]
DR   PDB; 4QGE; X-ray; 2.00 A; A/B=1-593.
DR   PDBsum; 4QGE; -.
DR   ProteinModelPortal; H2QL32; -.
DR   STRING; 9598.ENSPTRP00000024002; -.
DR   Ensembl; ENSPTRT00000026016; ENSPTRP00000024002; ENSPTRG00000013946. [H2QL32-1]
DR   GeneID; 474020; -.
DR   KEGG; ptr:474020; -.
DR   CTD; 5152; -.
DR   GeneTree; ENSGT00760000118889; -.
DR   InParanoid; H2QL32; -.
DR   KO; K13761; -.
DR   OMA; PRAFKIN; -.
DR   OrthoDB; EOG7DFXC4; -.
DR   TreeFam; TF314638; -.
DR   UniPathway; UPA00763; UER00748.
DR   Proteomes; UP000002277; Chromosome 21.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; ISS:UniProtKB.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046069; P:cGMP catabolic process; ISS:UniProtKB.
DR   GO; GO:0046068; P:cGMP metabolic process; ISS:UniProtKB.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   cGMP; Complete proteome; Cytoplasm; Endoplasmic reticulum;
KW   Golgi apparatus; Hydrolase; Magnesium; Membrane; Metal-binding;
KW   Reference proteome; Zinc.
FT   CHAIN         1    593       High affinity cGMP-specific 3',5'-cyclic
FT                                phosphodiesterase 9A.
FT                                /FTId=PRO_0000433156.
FT   NP_BIND     312    316       cGMP. {ECO:0000250|UniProtKB:O76083}.
FT   NP_BIND     512    513       cGMP. {ECO:0000250|UniProtKB:O76083}.
FT   REGION      288    550       Catalytic. {ECO:0000250}.
FT   ACT_SITE    312    312       Proton donor.
FT                                {ECO:0000250|UniProtKB:O76083}.
FT   METAL       316    316       Zinc; via tele nitrogen.
FT                                {ECO:0000244|PDB:4QGE,
FT                                ECO:0000269|PubMed:25432025}.
FT   METAL       352    352       Zinc; via tele nitrogen.
FT                                {ECO:0000244|PDB:4QGE,
FT                                ECO:0000269|PubMed:25432025}.
FT   METAL       353    353       Magnesium. {ECO:0000244|PDB:4QGE,
FT                                ECO:0000269|PubMed:25432025}.
FT   METAL       353    353       Zinc. {ECO:0000244|PDB:4QGE,
FT                                ECO:0000269|PubMed:25432025}.
FT   METAL       462    462       Zinc. {ECO:0000244|PDB:4QGE,
FT                                ECO:0000269|PubMed:25432025}.
FT   BINDING     353    353       cGMP. {ECO:0000250|UniProtKB:O76083}.
FT   BINDING     462    462       cGMP. {ECO:0000250|UniProtKB:O76083}.
FT   BINDING     484    484       cGMP. {ECO:0000250|UniProtKB:O76083}.
FT   BINDING     484    484       Inhibitor specific to PDE9A.
FT                                {ECO:0000269|PubMed:25432025}.
FT   BINDING     513    513       Inhibitor. {ECO:0000269|PubMed:25432025}.
FT   VAR_SEQ      88    147       Missing (in isoform 2).
FT                                /FTId=VSP_057676.
FT   HELIX       250    255       {ECO:0000244|PDB:4QGE}.
FT   HELIX       263    265       {ECO:0000244|PDB:4QGE}.
FT   HELIX       268    281       {ECO:0000244|PDB:4QGE}.
FT   HELIX       284    287       {ECO:0000244|PDB:4QGE}.
FT   HELIX       292    304       {ECO:0000244|PDB:4QGE}.
FT   STRAND      310    313       {ECO:0000244|PDB:4QGE}.
FT   HELIX       314    330       {ECO:0000244|PDB:4QGE}.
FT   HELIX       333    335       {ECO:0000244|PDB:4QGE}.
FT   HELIX       339    351       {ECO:0000244|PDB:4QGE}.
FT   TURN        352    355       {ECO:0000244|PDB:4QGE}.
FT   HELIX       361    366       {ECO:0000244|PDB:4QGE}.
FT   HELIX       370    374       {ECO:0000244|PDB:4QGE}.
FT   TURN        375    377       {ECO:0000244|PDB:4QGE}.
FT   HELIX       380    394       {ECO:0000244|PDB:4QGE}.
FT   HELIX       396    398       {ECO:0000244|PDB:4QGE}.
FT   TURN        400    403       {ECO:0000244|PDB:4QGE}.
FT   HELIX       406    421       {ECO:0000244|PDB:4QGE}.
FT   HELIX       425    427       {ECO:0000244|PDB:4QGE}.
FT   HELIX       428    438       {ECO:0000244|PDB:4QGE}.
FT   HELIX       439    441       {ECO:0000244|PDB:4QGE}.
FT   HELIX       447    462       {ECO:0000244|PDB:4QGE}.
FT   HELIX       465    467       {ECO:0000244|PDB:4QGE}.
FT   HELIX       470    492       {ECO:0000244|PDB:4QGE}.
FT   TURN        493    495       {ECO:0000244|PDB:4QGE}.
FT   HELIX       500    502       {ECO:0000244|PDB:4QGE}.
FT   TURN        504    506       {ECO:0000244|PDB:4QGE}.
FT   HELIX       509    519       {ECO:0000244|PDB:4QGE}.
FT   HELIX       521    531       {ECO:0000244|PDB:4QGE}.
FT   HELIX       534    538       {ECO:0000244|PDB:4QGE}.
FT   HELIX       540    562       {ECO:0000244|PDB:4QGE}.
SQ   SEQUENCE   593 AA;  68449 MW;  A3235CB335EC82C7 CRC64;
     MGSGSSSYRP KAIYLDIDGR IQKVIFSKYC NSSDIMDLFC IATGLPRNTT ISLLTTDDAM
     VSIDPTMPAN SERTPYKVRP VAIKQLSAGV EDKRTTSRGQ SAERPLRDRR VVGLEQPRRE
     GAFESGQVEP RPREPQGCCQ EGQRIPPERE ELIQSVLAQV AEQFSRAFKI NELKAEVANH
     LAVLEKRVEL EGLKVVEIEK CKSDIKKMRE ELAARSSRTN CPCKYSFLDN HKKLTPRRDV
     PTYPKYLLSP ETIEALRKPT FDVWLWEPNE MLSCLEHMYH DLGLVRDFSI NPVTLRRWLF
     CVHDNYRNNP FHNFRHCFCV AQMMYSMVWL CSLQENFSQM DILILMTAAI CHDLDHPGYN
     NTYQINARTE LAVRYNDISP LENHHCAVAF QILAEPECNI FSNIPPDGFK QIRQGMITLI
     LATDMARHAE IMDSFKEKME NFDYSNEEHM TLLKMILIKC CDISNEVRPM EVAEPWVDCL
     LEEYFMQSDR EKSEGLPVAP FMDRDKVTKA TAQIGFIKFV LIPMFETVTK LFPMVEEIML
     QPLWESRDRY EELKRIDDAM KELQKKTDSL TSGATEKSRE RSRDVKNSEG DCA
//
